Radiation Enteritis

2

Review clinical trials related to Radiation Enteritis. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Efficacy and Safety of Thalidomide Combined With Glutamine in the Treatment of Radiation Intestinal Injury.

At present, there is still a lack of standard and effective treatment strategies and procedures for radiation intestinal injury. Studies have shown that thalidomide can effectively treat refractory gastrointestinal bleeding caused by vascular malformation. Therefore, The investigators designed a single-center, open-label, randomized controlled study to evaluate the efficacy and safety of thalidomide combined with glutamine in the treatment of radiation intestinal injury.

Participants needed: 150
Trial details
Phase: Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: Yongquan ShiUpdated: Mar 27, 2026Locations: 1
Eligibility criteria

Age 18-80 years old, gender is not limited; [+3]

Patients with hemodynamic instability; [+8]

Status: Recruiting

Fecal Microbiota Transplantation for Radiation Enteritis

Radiation enteritis is one of the most feared complications after abdominal or pelvic radiation therapy.The gut microbiota is considered to constitute a "microbial organ" which has pivotal roles in the intestinal diseases and body metabolism. Evidence from animal studies demonstrated the link between intestinal bacteria and radiation enteritis. This clinical trial aims to evaluate the efficacy and safety of fecal microbiota transplantation (FMT) for radiation enteritis.

Participants needed: 70
Trial details
Age: 18-85Biological sex: AllType: InterventionalSponsor: The Second Hospital of Nanjing Medical UniversityUpdated: Mar 30, 2025Locations: 1
Eligibility criteria

age ≥18 years old; [+1]

Patients who were pregnant or nursing; [+3]